CN109675030A - A kind of compound washing lotion of immune globulin IgY for gynaecological imflammation - Google Patents
A kind of compound washing lotion of immune globulin IgY for gynaecological imflammation Download PDFInfo
- Publication number
- CN109675030A CN109675030A CN201910030944.6A CN201910030944A CN109675030A CN 109675030 A CN109675030 A CN 109675030A CN 201910030944 A CN201910030944 A CN 201910030944A CN 109675030 A CN109675030 A CN 109675030A
- Authority
- CN
- China
- Prior art keywords
- yolk antibody
- washing lotion
- gardnerella
- gynecological disease
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The invention belongs to fields of biomedicine, and in particular to a kind of gynaecologic washing lotion.It include composite yolk antibody and nano silver in the washing lotion.Wherein, composite yolk antibody is obtained by Gardnerella, trichomonas vaginalis as antigen direct immunization laying hen.After washing lotion cleaning vagina of the invention, the anti-Gardnerella of high activity, Antibody of Trichomonas Vaginalis are inputted to gynaecological imflammation patient.In conjunction with nano silver, the compound washing lotion of gynaecological imflammation for meeting Yolk antibody and preparation of the invention is significant for the anti-recurrence after the preventing, treating, cure of gynecological disease caused by vagina infection.
Description
Technical field
The invention belongs to fields of biomedicine, and in particular to a kind of immunoglobulin gynaecologic washing lotion for gynaecological imflammation.
Background technique
Bacterial vaginosis BV (bacterial vaginosis, BV) can increase the risk that women suffers from pelvic inflammatory disease, increase
Add the neurological susceptibility to sexually transmitted disease and leads to the consequences such as Disadvantage pregnancy.Gardnerella vaginalis (GV) is the weight of bacterial vaginosis BV
Want one of pathogenic bacteria.Gardnerella vaginitis is one kind also known as haemophilus property vaginitis of bacterial vaginosis BV, is by adding
Moral receives a kind of vagina mucosa inflammation caused by bacillus, and passability, which is handed over, to be infected.
Gardner bacillus is the tiny bacillus of Gram-negative, is often in club-shaped, sometimes in Filamentous and Multiple Shape, common the two poles of the earth
Dyeing.It is 0.4--0.6 microns wide, long 1--2 microns of size, inactivity, atrichia, without gemma.Many bacterial strains have pod membrane.In people
It must be accorded to new blood ability growth and breeding when work culture, therefore have the title of " bloodthirsty ".But its biological nature and haemophilus are not
Identical to the greatest extent, clinically caused vaginitis is nonspecific vaginitis.
Infection caused by Gardner bacillus is most lighter, and the property be more common in enlivens women.Acute stage leucorrhea increasing, have fish raw meat or
The stink of ammonia, vulva is moist uncomfortable, is often accompanied by vagina burning heat sensation, intercourse pain and pudendal pruritus.Inspection is shown in that some patientss vulva is red
Swollen, vagina mucosa is congested, is in bois de rose, and mild redness, secretion is in homogenieity more, thin, canescence, sometimes for milk yellow or
Class green, bad smell.Vagina pH is often 5--5.5.Sometimes leukorrhea amount is few, only thin layer, as film sample is covered on congested yin
On road wall.Small number of patients vaginal wall has erythema or petechiae, and pregnant patient can cause miscarriage or puerperal endometritis.Infect severe one
It may also lead to septicemia, urinary tract infection, perinephric abscess and cystitis etc..Using metronidazole or Moxifloxacin standard care, though face
Bed symptom disappears, but easy to recur after drug withdrawal.
It there is no the drug that can be treated Gardnerella vaginitis and prevent recurrence at present.Meanwhile vaginitis is more sometimes
Caused by kind pathogen mixed infection.
Therefore a kind of compound formulation of gynaecological imflammation is developed, ingredient includes the Yolk antibody of Gardnerella and pharmaceutically may be used
The carrier of receiving.
Summary of the invention
In view of this, the purpose of the present invention is to provide one kind to be used to prepare gynaecology's disease caused by preventing/treating vagina infection
The composition of the drug of disease, formula is safe, simple, and the drug of preparation can reduce the recurrence rate of vaginitis, to easy to recur
Gardnerella vagina infection cure rate is high.
To achieve the above object, the technical solution of the present invention is as follows:
A kind of composition for the drug being used to prepare gynecological disease caused by preventing/treating vagina infection, which is characterized in that institute
The active constituent for stating composition is composite yolk antibody；The composition also includes nano silver；
The composite yolk antibody is obtained by Gardnerella, trichomonas vaginalis as antigen immunization laying hen.
Yolk antibody (Immunoglobulin of yolk, IgY) is by inoculation laying hen, by the egg of its production
Corresponding antibody is extracted in Huang, and can be used for the prevention and treatment of corresponding disease.
Main component in yolk is protein and fat.Most of protein is all lipoprotein, is present in yolk protein
In, not soluble in water, only livitin (α, β, γ) is water-soluble, and IgY is γ livitin.Therefore point of IgY
From purifying firstly the need of the lipid being effectively removed in yolk, IgY is separated from water-solubility protein.
Had been established many more efficient economic methods, these methods mostly with PEG, dextran sulfate, natural gum,
As the methods of glycan or ethanol precipitation preliminary purification protein are pitched in mosanom, angle.
The method of industrial large-scale production IgY has: supercritical carbon dioxide gas extraction process, carragheen method, ammonium sulfate
Salting out method.
Preferably, the composite yolk antibody, nano silver proportion be 10-20 parts by weight: 0.2-1 parts by weight.
The preparation method of above-mentioned composite yolk antibody the following steps are included:
1) Gardnerella and trichomonas vaginalis are cultivated, is crushed after mixing, is homogenized acquisition antigen；
2) the antigen immunization laying hen for obtaining step 1) takes the egg of the laying hen after being immunized, and obtains yolk；
3) composite yolk antibody of the Gardnerella and trichomonas vaginalis in yolk is purified.
Preferably, Gardnerella described in step 1) and the mass ratio of trichomonas vaginalis are 1:1.
Such as without special specified, the unit of weight of the parts by weight in the traditional chinese medicine composition of the invention formula and the volume list of parts by volume
Position is matching relationship.That is: when the unit of weight of parts by weight is Kg, the volume unit of parts by volume is L；When the weight list of parts by weight
When position is g, the volume unit of parts by volume is mL.
Composition of the invention can also be prepared any as needed for can directly give in the form of a solution when treating
Pharmaceutically acceptable dosage form.The pharmaceutically acceptable dosage form includes composition of the invention and optional one or more pharmacy
Upper acceptable carrier, diluent or excipient and step suitable during the preparation process addition.Term used in the present invention
" pharmaceutically acceptable " refers to such compound, raw material, composition and/or dosage form, the model that they judge in rational medicine
In enclosing, be suitable for contacting with patient tissue and without excessive toxicity, irritation, allergy or with reasonable interests/Hazard ratio phase
Symmetrical other problems and complication, and effective for given application.
Pharmaceutical preparation of the invention is suitable for local administration, can be made into ointment, cream, suspension, lotion, powder, molten
Liquor, paste, gelling agent, spray, aerosol, oil formulation or transdermal patch.
Preferably, the drug of the preventing/treating gynecological disease of composition of the invention preparation further includes other active components.
Preferably, the gynecological disease of the drug therapy of the preventing/treating gynecological disease of composition of the invention preparation is mould
Vaginitis caused by bacterium property vaginitis, trichomonas vaginitis, bacterial vaginitis, gonococcal vaginitis, vagina mixed infection.
Preferably, the gynecological disease is interior negative itch, cervical erosion, peculiar smell of smelling as of rotten fish, leucorrhea increasing caused by vagina infection.
The second object of the present invention is to provide a kind of washing lotion of gynecological disease caused by preventing/treating vagina infection, energy
The recurrence rate for enough reducing vaginitis is high to Gardnerella vagina infection cure rate easy to recur.
The washing lotion of gynecological disease caused by a kind of preventing/treating vagina infection, which is characterized in that the formula of the washing lotion is such as
Under: composite yolk antibody 10-20 parts by weight, 1000ppm nano silver aqueous dispersion 200-300 parts by volume, water 1500-2000
Parts by volume；
The composite yolk antibody is immunized as antigen after being mixed by Gardnerella, trichomonas vaginalis by weight 1:1 and produces
Laying hen obtains.
Further, the formula of the washing lotion is as follows: 20 parts by weight of composite yolk antibody, the water-soluble dispersion of 1000ppm nano silver
200 parts by volume of liquid, 1500 parts by volume of water；PH value is 5.5 ± 0.1.
The preparation method of above-mentioned composite yolk antibody the following steps are included:
1) Gardnerella and trichomonas vaginalis are cultivated, is crushed after mixing, is homogenized acquisition antigen；
2) the antigen immunization laying hen for obtaining step 1) takes the egg of the laying hen after being immunized, and obtains yolk；
3) composite yolk antibody of the Gardnerella and trichomonas vaginalis in yolk is purified.
The beneficial effects of the present invention are: the drug of gynecological disease caused by preventing/treating vagina infection provided by the invention
Composition:
1) recurrence rate for reducing vaginitis is high to Gardnerella vagina infection cure rate easy to recur；
2) ingredient safety, antibiotic-free do not generate drug resistance；
3) directly outer to be used for infection site, it is good to prevent, treat effect.
Specific embodiment
It detailed description of a preferred embodiment of the present invention will be given below.The reality of actual conditions is not specified in preferred embodiment
Proved recipe method, usually according to normal condition, illustrated embodiment are but not to be to preferably be illustrated to the contents of the present invention
The contents of the present invention are only limitted to illustrated embodiment.So those skilled in the art are according to foregoing invention content to embodiment party
Case carries out nonessential modifications and adaptations, still falls within protection scope of the present invention.
The specificity composite IgY antibody of the anti-gynecological inflammation pathogen of embodiment 1
1, prepared by antigen
Trichomonas vaginalis, Gardnerella are absorbed from vaginitis patient's body, and uses conventional method culture.
Obtained trichomonas vaginalis, Gardnerella are mixed in the ratio of 1:1 and crushed with conventional method, is placed into
It is sufficiently smashed to pieces and is stirred evenly with 8000-12000rpm in " tissue mashing refiner ".Then by this mixed liquor with 1-10:1-10's
Freund adjuvant is added in ratio (usually 1:1), is placed in high speed homogenizer and is homogenized with 30000rpm high speed, forms water-in-oil emulsion,
Obtain complex antigen.
2, Antibody preparation
1) it is immunized:
1. the selected bird inlay with high immune response ability is made using immune activation method using step
The complex antigen obtained carries out injecting immune.It is spaced 7 days after first time injects, then for the second time with same dosage, method injection, the
It is spaced after biphasic injection 7 days and is injected the 3rd time with same dose again, pick high immune egg after injecting for the first time since the 20th day.
2) preparation of IgY crude product:
Respectively by produced high immune egg 0.5% benzalkonium bromide solution or 0.1%KMnO4 solution or other similar disinfections
Liquid, which impregnates immune egg 15-30 minutes, to be sterilized, and sterile distilled water is rinsed, dried, and is placed in eggbeater and is smashed eggshell, uses yolk
Sieving is added 4-8 times of distilled water dilution except egg white leaves yolk and stirs evenly, with 1mol/l NaOH liquid or 1mol/l HCL liquid
PH to 5.5-6.0 is adjusted, is stood overnight at 4-6 DEG C, dilution 8,000-12 000r/min high speed centrifugation 20 minutes, takes supernatant
Liquid is concentrated by ultrafiltration with ultrafilter.
Using the U.S. Pall Ultrafine Filtration Company manufacture except virus filtration system bacterial disease
Malicious filtering device thoroughly filters out various bacterial viruses, it is ensured that prepared IgY never contains any virus and bacterium.
First of bacterium filtering device is to remove bacteriums such as detection of Salmonella (Salmonella) with 0.22 μm of film sterilizing filter；
Second mycoplasma filtering device is to remove mycoplasma filter with 0.1 μm of film to remove mycoplasma；Third road virus filtering device is
A variety of viruses of the virus filter removing including avian influenza virus, enterovirus are removed with Ultipor VFTM DV50.
3) bioactivity:
It is above obtained using enzyme-linked immunization (ELISA) detection respectively using trichomonas vaginalis, Gardnerella as antigen
Anti- gynecological inflammation pathogen specific IgY semifinished product antibody combination potency.
Testing result is shown in Table 1:
1 bioactivity result of table
Testing result shows that the antibody combination potency of obtained anti-gynecological inflammation pathogen specific IgY is higher, completely
The requirement of medical treatment is reached.
4) prepared by IgY sterling:
Obtained anti-gynecological inflammation pathogen specific IgY crude product is crossed respectively ion exchange column and washing lotion exchange column with
And affinity column is purified to get the pure IgY of anti-gynecological inflammation pathogen specific；
Obtained anti-gynecological inflammation pathogen specific IgY application freeze drier is dry, it is scorching to obtain anti-gynaecology
Disease pathogen specific IgY dry powder.
Obtained anti-gynecological inflammation pathogen specific IgY dry powder is taken, crushing of milling, processing is added in micronizer
At size between 1-100nm, granularity be more than >=15000 mesh ultramicron, corresponding nanosizing anti-gynaecological imflammation disease is made
Substance specific IgY dry powder.
Using SDS-PAGE electrophoresis assays, to the anti-gynecological inflammation pathogen specific IgY produced by process above
Sterling is detected, and measuring wherein IgY content is 98% or more.
Embodiment 2 treats the composition 1 of gynaecological imflammation and the composite yolk antibody washing lotion of preparation
Composite yolk antibody 20g, 1000ppm nano silver the aqueous dispersion 200ml, water 1500ml that embodiment 1 obtains；
It is 5.5 ± 0.1 that pH value is adjusted after mixing, obtains washing lotion.
Embodiment 3 treats the composition 2 of gynaecological imflammation and the composite yolk antibody washing lotion of preparation
Composite yolk antibody 15g, 1000ppm nano silver the aqueous dispersion 300ml, water 2000ml that embodiment 1 obtains；
It is 5.5 ± 0.1 that pH value is adjusted after mixing, obtains washing lotion.
Embodiment 4 treats the composition 3 of gynaecological imflammation and the composite yolk antibody washing lotion of preparation
Composite yolk antibody 10g, 1000ppm nano silver the aqueous dispersion 200ml, water 1500ml that embodiment 1 obtains；
It is 5.5 ± 0.1 that pH value is adjusted after mixing, obtains washing lotion.
5 validity check of embodiment
1. clinical test
1. subjects: selection vaginitis patient 73, the age 19-58 years old.
2. testing process
Subjects are divided into experimental group and control group, use composite yolk antibody washing lotion (embodiment 2) of the invention respectively
(37) and ultrapure water (36).
Collection of specimens: in the non-menstrual period sampling of patient, vagina innerlich anwenden is avoided before sampling.
Treatment cycle: subjects are treated with metronidazole suppository first, and treatment cycle is 2 months, are carried out after turning out cloudy
Follow-up test.
Experimental group uses washing lotion of the invention, and using 2 months, first month removed menstrual period and menstrual period front and back each 3 beyond the highest heavens, even
Continuous to use this product 18 days, daily vaginadouche is primary, each dosage 10ml；The 2nd month next day, uses.It is checked after deactivating January.It is right
Ultrapure water is used according to group, usage, dosage are identical as experimental group, check after deactivating January.
2. result:
Composite yolk antibody washing lotion experimental group clinical effectiveness is shown, deactivates after January negative case number 30, the positive 7 is multiple
Hair rate 20%；Control group negative case number 21,15 positive, recurrence rate 41.7%.
Composite yolk antibody of the invention and the recurrence anti-for vaginitis patient of composite yolk antibody washing lotion have important as a result,
Effect, recurrence rate can be substantially reduced.Solve the problems, such as that vaginitis is easy to recur to a certain extent.
Finally, it is stated that the above examples are only used to illustrate the technical scheme of the present invention and are not limiting, although referring to compared with
Good embodiment describes the invention in detail, those skilled in the art should understand that, it can be to skill of the invention
Art scheme is modified or replaced equivalently, and without departing from the objective and range of technical solution of the present invention, should all be covered at this
In the scope of the claims of invention.
Claims (10)
1. a kind of composition for the drug for being used to prepare gynecological disease caused by preventing/treating vagina infection, which is characterized in that described
The active constituent of composition is composite yolk antibody；The composition also includes nano silver；
The composite yolk antibody is obtained by Gardnerella, trichomonas vaginalis as antigen immunization laying hen.
2. composition according to claim 1-3, characteristic are, the composite yolk antibody, nano silver
Proportion is 10-20 parts by weight: 0.2-1 parts by weight.
3. composition according to claim 1, characteristic are, the preparation method of the composite yolk antibody includes following
Step:
1) Gardnerella and trichomonas vaginalis are cultivated, is crushed after mixing, is homogenized acquisition antigen；
2) the antigen immunization laying hen for obtaining step 1) takes the egg of the laying hen after being immunized, and obtains yolk；
3) composite yolk antibody of the Gardnerella and trichomonas vaginalis in yolk is purified.
4. composition according to claim 3, which is characterized in that Gardnerella described in step 1) and trichomonas vaginalis
Mass ratio is 1:1.
5. the described in any item compositions of claim 1-4 are in the drug for preparing gynecological disease caused by preventing/treating vagina infection
In application, which is characterized in that the drug of the treatment gynecological disease can be any pharmaceutically acceptable dosage form.
6. the described in any item compositions of claim 1-4 are in the drug for preparing gynecological disease caused by preventing/treating vagina infection
In application, which is characterized in that it is described preparation treatment gynecological disease drug further include other active components.
7. the described in any item compositions of claim 1-4 are in the drug for preparing gynecological disease caused by preventing/treating vagina infection
In application, which is characterized in that the vaginitis is trichomonas vaginitis, bacterial vaginitis, yin caused by vagina mixed infection
Road is scorching.
8. the described in any item compositions of claim 1-4 are in the drug for preparing gynecological disease caused by preventing/treating vagina infection
In application, which is characterized in that the gynecological disease is interior negative itch, cervical erosion caused by vagina infection, peculiar smell of smelling as of rotten fish, leukorrhea
Increase.
9. a kind of washing lotion of gynecological disease caused by preventing/treating vagina infection, which is characterized in that the formula of the washing lotion is as follows:
Composite yolk antibody 10-20 parts by weight, 1000ppm nano silver aqueous dispersion 200-300 parts by volume, water 1500-2000 body
Product part；
The composite yolk antibody is used as antigen immunization laying hen after being mixed by Gardnerella, trichomonas vaginalis by weight 1:1
It obtains.
10. washing lotion according to claim 9, which is characterized in that the formula of the washing lotion is as follows: 20 weight of composite yolk antibody
Measure part, water-soluble 200 parts by volume of dispersion liquid of 1000ppm nano silver, 1500 parts by volume of water；PH value is 5.5 ± 0.1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910030944.6A CN109675030A (en) | 2019-01-14 | 2019-01-14 | A kind of compound washing lotion of immune globulin IgY for gynaecological imflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910030944.6A CN109675030A (en) | 2019-01-14 | 2019-01-14 | A kind of compound washing lotion of immune globulin IgY for gynaecological imflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109675030A true CN109675030A (en) | 2019-04-26 |
Family
ID=66193167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910030944.6A Pending CN109675030A (en) | 2019-01-14 | 2019-01-14 | A kind of compound washing lotion of immune globulin IgY for gynaecological imflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109675030A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117244057A (en) * | 2023-09-20 | 2023-12-19 | 江苏润洁生物科技有限公司 | Preparation method of clinical egg yolk antibody product for gynecological inflammation |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1454901A (en) * | 2003-06-10 | 2003-11-12 | 雅臣药业集团（远东）有限公司 | Gynaecological anti-infective specificity IgY and its combined preparation |
| CN1616004A (en) * | 2004-09-17 | 2005-05-18 | 西安交通大学 | Suppository for treating bacterial vaginitis |
| US20060223765A1 (en) * | 2005-03-30 | 2006-10-05 | Kimberly-Clark Worldwide, Inc. | Method for inhibiting and/or treating vaginal infection |
| CN104474547A (en) * | 2015-01-07 | 2015-04-01 | 蓝佳堂生物医药（福建）有限公司 | Vaginal infection prevention immune globulin compound preservative |
-
2019
- 2019-01-14 CN CN201910030944.6A patent/CN109675030A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1454901A (en) * | 2003-06-10 | 2003-11-12 | 雅臣药业集团（远东）有限公司 | Gynaecological anti-infective specificity IgY and its combined preparation |
| CN1616004A (en) * | 2004-09-17 | 2005-05-18 | 西安交通大学 | Suppository for treating bacterial vaginitis |
| US20060223765A1 (en) * | 2005-03-30 | 2006-10-05 | Kimberly-Clark Worldwide, Inc. | Method for inhibiting and/or treating vaginal infection |
| CN104474547A (en) * | 2015-01-07 | 2015-04-01 | 蓝佳堂生物医药（福建）有限公司 | Vaginal infection prevention immune globulin compound preservative |
Non-Patent Citations (2)
| Title |
|---|
| 王芳等: "纳米银材料在妇科疾病中的应用", 《中国组织工程研究与临床康复》 * |
| 瞿秀芳: "纳米银抗菌凝胶治疗阴道炎的疗效观察", 《齐齐哈尔医学院学报》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117244057A (en) * | 2023-09-20 | 2023-12-19 | 江苏润洁生物科技有限公司 | Preparation method of clinical egg yolk antibody product for gynecological inflammation |
| CN117244057B (en) * | 2023-09-20 | 2024-05-14 | 江苏润洁生物科技有限公司 | Preparation method of clinical egg yolk antibody product for gynecological inflammation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101328219B (en) | Nano liposome anti-HPV, gynecological inflammation pathogen specific compound IgY and combined preparation thereof | |
| CN101690810B (en) | Tetravalent inactivated vaccine adjuvant against Newcastle Disease, infectious bronchitis, egg drop syndrome and bird flu and preparation method thereof | |
| AU2011281247B2 (en) | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition | |
| CN109602904A (en) | A kind of immune globulin IgY plural gel agent for gynaecological imflammation | |
| CN103800772A (en) | Gynecological external lotion for preventing and treating vagina inflammatory diseases and preparation method thereof | |
| CN108250300A (en) | A kind of preparation method of nanoparticle type anti-human papilloma virus (anti-HPV) and the polyclonal combination IgY antibody of gynecological inflammation pathogen | |
| CN105168385B (en) | A kind of pharmaceutical composition of anti-bacterial, anti-itching and preparation method thereof | |
| CN109675030A (en) | A kind of compound washing lotion of immune globulin IgY for gynaecological imflammation | |
| CN1454901A (en) | Gynaecological anti-infective specificity IgY and its combined preparation | |
| CN103142683B (en) | Be used for the treatment of Chinese medicinal perfusion liquid containing Herba Sophorae alopecuroidis total alkali of bovine mastitis and endometritis and preparation method thereof | |
| CN101690812B (en) | Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease-infectious bursal disease and preparation process thereof | |
| CN106177900B (en) | A kind of gel of anti-human papilloma virus (anti-HPV) and preparation method thereof | |
| CN103599437B (en) | One treats colpitic traditional Chinese medicine liquid | |
| CN106491683A (en) | A kind of for treating Flos Farfarae extract of asthma and preparation method thereof | |
| CN102731652A (en) | Preparation method of nanoliposome anti-bovine mastitis drug-resistant pathogenic bacteria specific composite IgY and its preparation | |
| CN101301389B (en) | Chinese medicinal composition for treating mammilla and lacteal cistern neoplasm disease of milk cattle and preparation and use thereof | |
| CN110624044A (en) | Gel disinfectant for treating eczema and preparation method thereof | |
| CN104436078A (en) | Chinese medicine prescription for treating renal calculus | |
| CN107362310A (en) | It is a kind of to be used to repair Baicao Fuyanqing preparation of vagina environment and preparation method thereof | |
| CN104815052B (en) | A kind of Chinese medicine composition of resisiting influenza virus infection and preparation method thereof | |
| CN107519355B (en) | Green plum for treating throat diseases and preparation method thereof | |
| CN107837289A (en) | It is a kind of to be used to treat breast inflammation of milk cattle and the medicine of carbuncle swells and preparation method thereof | |
| WO2004101621A1 (en) | A SPECIFIC IMMUNOGLOBULIN (Ig) Y AGAINST SEVERVE ACUTE RTESPIRATORY SYNDROME (SARS) AND A PREPARING METHOD THEREOF AND COMBINATION PREPARATIOS CONTAINING IT | |
| WO2009086695A1 (en) | Use of extractive of bcg polysaccharide and nucleic acid for preparing medicine for treating allergic dermatosis, and its injection and preparation method | |
| CN106173409A (en) | A kind of ablactational baby pig feed additive and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190426 |